Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients
Crossref DOI link: https://doi.org/10.1186/s12885-016-2840-x
Published Online: 2016-10-22
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wolf, Barbara
Goebel, Georg
Hackl, Hubert
Fiegl, Heidi
Funding for this research was provided by:
Verein zur Krebsforschung in der Frauenheilkunde
Österreichische Krebshilfe - Krebsgesellschaft Tirol (14065)
